Join
Live feed
·
PRReleasevia Quantisnow
Achilles Therapeutics plc logo

Achilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022

ByQuantisnow·Wall Street's wire, on your screen.
ACHL· Achilles Therapeutics plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACHL (Achilles Therapeutics plc) and more on Quantisnow.